<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23272637</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>06</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>02</Month>
            <Day>21</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1479-5876</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <PubDate>
                        <Year>2012</Year>
                        <Month>Dec</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of translational medicine</Title>
                <ISOAbbreviation>J Transl Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>256</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/1479-5876-10-256</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Interferon-γ (IFN-γ) is regarded as a potent antitumor agent, but its clinical application is limited by its short half-life and significant side effects. In this paper, we tried to develop IFN-γ gene therapy by a replication defective adenovirus encoding the human IFN-γ (Ad-IFNγ), and evaluate the antitumoral effects of Ad-IFNγ on nasopharyngeal carcinoma (NPC) cell lines in vitro and in xenografts model.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The mRNA levels of human IFN-γ in Ad-IFNγ-infected NPC cells were detected by reverse transcription-polymerase chain reaction (RT-PCR), and IFN-γ protein concentrations were measured by enzyme-linked immunosorbent assay (ELISA) in the culture supernatants of NPC cells and tumor tissues and bloods of nude mice treated with Ad-IFNγ. The effects of Ad-IFNγ on NPC cell proliferation was determined using MTT assay, cell cycle distribution was determined by flow cytometry analysis for DNA content, and cells apoptosis were analyzed by Annexin V-FITC/7-AAD binding assay and hoechst 33342/PI double staining. The anti-tumor effects and toxicity of Ad-IFNγ were evaluated in BALB/c nude mice carrying NPC xenografts.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The results demonstrated that Ad-IFNγ efficiently expressed human IFN-γ protein in NPC cell lines in vitro and in vivo. Ad-IFNγ infection resulted in antiproliferative effects on NPC cells by inducing G1 phase arrest and cell apoptosis. Intratumoral administration of Ad-IFNγ significantly inhibited the growth of CNE-2 and C666-1 cell xenografts in nude mice, while no significant toxicity was observed.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings indicate IFN-γ gene therapy mediated by replication defective adenoviral vector is likely a promising approach in the treatment of nasopharyngeal carcinoma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Ran-yi</ForeName>
                    <Initials>RY</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 651 Dong-feng Road East, Guangzhou, 510060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Ying-hui</ForeName>
                    <Initials>YH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Peng</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Hong-li</ForeName>
                    <Initials>HL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Lan-cai</ForeName>
                    <Initials>LC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Hong-yu</ForeName>
                    <Initials>HY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Huan-xin</ForeName>
                    <Initials>HX</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Liang</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Jiang-xue</ForeName>
                    <Initials>JX</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Wenlin</ForeName>
                    <Initials>W</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2012</Year>
                <Month>12</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Transl Med</MedlineTA>
            <NlmUniqueID>101190741</NlmUniqueID>
            <ISSNLinking>1479-5876</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>82115-62-6</RegistryNumber>
                <NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D059585" MajorTopicYN="N">G1 Phase Cell Cycle Checkpoints</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018014" MajorTopicYN="Y">Gene Transfer Techniques</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015316" MajorTopicYN="Y">Genetic Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077274" MajorTopicYN="N">Nasopharyngeal Carcinoma</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009303" MajorTopicYN="N">Nasopharyngeal Neoplasms</DescriptorName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D023041" MajorTopicYN="N">Xenograft Model Antitumor Assays</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2012</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>1</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>6</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23272637</ArticleId>
            <ArticleId IdType="pii">1479-5876-10-256</ArticleId>
            <ArticleId IdType="doi">10.1186/1479-5876-10-256</ArticleId>
            <ArticleId IdType="pmc">PMC3573957</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2000 Jan-Feb;7(1):151-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10601610</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2007 Aug 9;81(9):695-701</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17714738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2000 Mar;82(6):1138-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10735496</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Biosci. 2000 Apr 1;5:D479-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10762599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2000 Jun 16;272(3):674-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10860813</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2000 Jul 15;60(14):3904-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10919667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut. 2001 Aug;49(2):251-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11454803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2002 Mar 4;86(5):768-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11875741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine Growth Factor Rev. 2002 Apr;13(2):95-109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11900986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2002 Sep;8(9):2942-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12231540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2002 Oct;8(10):3298-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12374702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Apoptosis. 2003 Jun;8(3):237-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12766484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2003 Jul;9(7):2487-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12855622</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2004 Feb;75(2):163-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14525967</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2004 May 7;279(19):19712-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14993214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2004 Sep 15;104(6):1631-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15161670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1984 Feb;81(3):886-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6608104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Immunol. 1993;11:571-611</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8476573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 1997 Jan 24;88(2):277-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9008168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Immunol. 1997;15:749-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9143706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1998 Feb 20;273(8):4642-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9468523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Apr 1;65(7):2906-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15805293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Apr 15;65(8):3447-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15833880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2005 Jul;41(10):1474-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15949937</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Res. 2005;32(1-3):231-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16106075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Oct 1;65(19):8869-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16204058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Oct 1;65(19):9056-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16204080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2006 Apr 15;118(8):2064-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16287067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Circ Res. 2006 Mar 17;98(5):617-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16484616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2006 Aug 1;12(15):4702-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16899621</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2006 Nov-Dec;26(6B):4115-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17201122</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2008 Sep 26;374(3):479-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18639520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2008 Sep-Oct;28(5B):2843-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19031923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Cancer Res. 2008;101:249-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19055946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Rev. 2008 Dec;226:41-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19161415</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2009;9:55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19216804</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Sci. 2009 Jun 15;122(Pt 12):2064-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19470579</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1070-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19231110</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2009 Nov 15;183(10):6413-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19841170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosurg Clin N Am. 2010 Jan;21(1):77-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19944968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2009 Dec;1182:69-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20074276</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther. 2010 Jun;18(6):1244-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20372104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2011 Mar 25;331(6024):1565-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21436444</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2011 Oct 1;17(19):6118-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21705455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2011 Dec 1;30(48):4814-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21625209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin J Cancer. 2012 Apr;31(4):185-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22313595</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin J Cancer. 2012 Dec;31(12):573-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22776232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Gene Ther. 2000 Jan 20;11(2):247-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10680839</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>